BSE Live
Feb 06, 16:01Prev. Close
169.90
Open Price
161.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Profit & Loss account of Trident Texofab (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | |
| 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||
| Revenue From Operations [Gross] | 62.56 | 60.46 | 34.49 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 62.56 | 60.46 | 34.49 | |
| Total Operating Revenues | 62.56 | 60.46 | 34.49 | |
| Other Income | 0.10 | 0.06 | 0.00 | |
| Total Revenue | 62.65 | 60.52 | 34.49 | |
| EXPENSES | ||||
| Cost Of Materials Consumed | 59.32 | 57.61 | 31.99 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.00 | 0.00 | |
| Employee Benefit Expenses | 0.87 | 0.79 | 0.51 | |
| Finance Costs | 0.80 | 0.88 | 0.69 | |
| Depreciation And Amortisation Expenses | 0.19 | 0.11 | 0.08 | |
| Other Expenses | 1.19 | 0.82 | 0.97 | |
| Total Expenses | 62.37 | 60.22 | 34.24 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.28 | 0.30 | 0.25 | |
| Exceptional Items | -0.03 | -0.01 | 0.00 | |
| Profit/Loss Before Tax | 0.25 | 0.29 | 0.25 | |
| Tax Expenses-Continued Operations | ||||
| Current Tax | 0.08 | 0.07 | 0.05 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.01 | 0.00 | 0.05 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.02 | |
| Total Tax Expenses | 0.07 | 0.06 | 0.13 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 0.18 | 0.22 | 0.12 | |
| Profit/Loss From Continuing Operations | 0.18 | 0.22 | 0.12 | |
| Profit/Loss For The Period | 0.18 | 0.22 | 0.12 | |
| OTHER ADDITIONAL INFORMATION | ||||
| EARNINGS PER SHARE | ||||
| Basic EPS (Rs.) | 0.73 | 0.90 | 0.49 | |
| Diluted EPS (Rs.) | 0.73 | 0.90 | 0.49 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017